Oscar G. Mandό

523 total citations
21 papers, 350 citations indexed

About

Oscar G. Mandό is a scholar working on Hepatology, Epidemiology and Rheumatology. According to data from OpenAlex, Oscar G. Mandό has authored 21 papers receiving a total of 350 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Hepatology, 13 papers in Epidemiology and 3 papers in Rheumatology. Recurrent topics in Oscar G. Mandό's work include Hepatitis C virus research (15 papers), Hepatitis B Virus Studies (11 papers) and Liver Disease Diagnosis and Treatment (8 papers). Oscar G. Mandό is often cited by papers focused on Hepatitis C virus research (15 papers), Hepatitis B Virus Studies (11 papers) and Liver Disease Diagnosis and Treatment (8 papers). Oscar G. Mandό collaborates with scholars based in Argentina, Australia and United Kingdom. Oscar G. Mandό's co-authors include Ezequiel Ridruejo, Sebastián Marciano, Adrián Gadano, Alejandra Villamil, Boris Elsner, Julio I. Maiztegui, Emily Schwarz, Raúl Adrover, Alfredo P. Martínez and Daniel Cocozzella and has published in prestigious journals such as Journal of Hepatology, World Journal of Gastroenterology and American Journal of Tropical Medicine and Hygiene.

In The Last Decade

Oscar G. Mandό

20 papers receiving 336 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Oscar G. Mandό Argentina 12 195 192 76 41 30 21 350
Mark S. Sulkowski United States 7 344 1.8× 383 2.0× 81 1.1× 32 0.8× 9 0.3× 14 432
William N. Katkov United States 10 329 1.7× 231 1.2× 27 0.4× 27 0.7× 59 2.0× 17 469
Victoria T. Mücke Germany 12 337 1.7× 348 1.8× 63 0.8× 34 0.8× 14 0.5× 29 503
E. K. W. Chiu China 6 263 1.3× 187 1.0× 32 0.4× 40 1.0× 82 2.7× 9 388
Faleh Z. Al-Faleh Saudi Arabia 15 602 3.1× 578 3.0× 56 0.7× 35 0.9× 15 0.5× 40 777
Javier Graus Spain 7 223 1.1× 250 1.3× 26 0.3× 7 0.2× 13 0.4× 14 323
N. Qurishi Germany 3 298 1.5× 353 1.8× 163 2.1× 17 0.4× 36 1.2× 5 438
María Sales Gilabert Spain 2 476 2.4× 534 2.8× 189 2.5× 10 0.2× 16 0.5× 5 624
Jeanne Serpaggi France 9 697 3.6× 738 3.8× 73 1.0× 10 0.2× 18 0.6× 9 799
Luis Viola Argentina 12 293 1.5× 268 1.4× 33 0.4× 24 0.6× 12 0.4× 32 493

Countries citing papers authored by Oscar G. Mandό

Since Specialization
Citations

This map shows the geographic impact of Oscar G. Mandό's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oscar G. Mandό with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oscar G. Mandό more than expected).

Fields of papers citing papers by Oscar G. Mandό

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Oscar G. Mandό. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oscar G. Mandό. The network helps show where Oscar G. Mandό may publish in the future.

Co-authorship network of co-authors of Oscar G. Mandό

This figure shows the co-authorship network connecting the top 25 collaborators of Oscar G. Mandό. A scholar is included among the top collaborators of Oscar G. Mandό based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Oscar G. Mandό. Oscar G. Mandό is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ridruejo, Ezequiel, Sebastián Marciano, Omar Galdame, et al.. (2014). Efficacy and safety of long term entecavir in chronic hepatitis B treatment naïve patients in clinical practice. Annals of Hepatology. 13(3). 327–336. 9 indexed citations
2.
Marciano, Sebastián, Leila Haddad, Alfredo P. Martínez, et al.. (2014). Ultra-sensitive procalcitonin may help rule out bacterial infections in patients with cirrhosis. Annals of Hepatology. 13(5). 541–547. 12 indexed citations
3.
Ridruejo, Ezequiel, Marcelo Silva, & Oscar G. Mandό. (2013). Syncope during boceprevir treatment in hepatitis C. Annals of Hepatology. 12(5). 837–838.
4.
Ridruejo, Ezequiel, Sebastián Marciano, Omar Galdame, et al.. (2013). Relapse rates in chronic hepatitis B naïve patients after discontinuation of antiviral therapy with entecavir. Journal of Viral Hepatitis. 21(8). 590–596. 25 indexed citations
5.
Ridruejo, Ezequiel, Sebastián Marciano, Oscar G. Mandό, et al.. (2011). 1177 INTERLEUKIN-28B PREDICTS SVR IN LATIN AMERICAN HEPATITIS C GENOTYPE 1 PATIENTS TREATED WITH PEG IFN AND RIBAVIRIN. Journal of Hepatology. 54. S465–S465. 1 indexed citations
6.
Ridruejo, Ezequiel, Raúl Adrover, Daniel Cocozzella, et al.. (2011). Effectiveness of entecavir in chronic hepatitis B NUC-naive patients in routine clinical practice. International Journal of Clinical Practice. 65(8). 866–870. 18 indexed citations
7.
Ridruejo, Ezequiel, Ángela R. Solano, Sebastián Marciano, et al.. (2011). Genetic variation in Interleukin-28B predicts SVR in hepatitis C genotype 1 Argentine patients treated with PEG IFN and ribavirin. Annals of Hepatology. 10(4). 452–457. 18 indexed citations
8.
Ridruejo, Ezequiel, et al.. (2010). 1071 SHORT AND LONG TERM OUTCOME OF KIDNEY TRANSPLANTED PATIENTS WITH CHRONIC VIRAL HEPATITIS B AND C. Journal of Hepatology. 52. S414–S414. 2 indexed citations
9.
Ridruejo, Ezequiel, Raúl Adrover, Cristina Alonso, Oscar G. Mandό, & Marcelo Silva. (2010). Entecavir treatment for chronic hepatitis B infection in end‐stage renal disease and kidney transplantation. Dialysis & Transplantation. 39(9). 397–400. 11 indexed citations
10.
Ridruejo, Ezequiel, et al.. (2010). Short and long term outcome of kidney transplanted patients with chronic viral hepatitis B and C. Annals of Hepatology. 9(3). 271–277. 17 indexed citations
11.
Ridruejo, Ezequiel, et al.. (2007). Hepatitis C Virus Infection and Outcome of Renal Transplantation. Transplantation Proceedings. 39(10). 3127–3130. 8 indexed citations
12.
Ridruejo, Ezequiel, et al.. (2007). Imatinib-induced fatal acute liver failure. World Journal of Gastroenterology. 13(48). 6608–6608. 70 indexed citations
13.
Ridruejo, Ezequiel, et al.. (2006). Central hypothyroidism and hypophysitis during treatment of chronic hepatitis C with pegylated interferon alpha and ribavirin. European Journal of Gastroenterology & Hepatology. 18(6). 693–694. 27 indexed citations
14.
Ridruejo, Ezequiel, et al.. (2005). Hepatocellular Carcinoma in Renal Transplant Patients. Transplantation Proceedings. 37(5). 2086–2088. 11 indexed citations
15.
Ridruejo, Ezequiel & Oscar G. Mandό. (2005). Chylous ascites as the main manifestation of left ventricular dysfunction: a case report. BMC Gastroenterology. 5(1). 25–25. 11 indexed citations
16.
Mathet, Verónica L., Mariana Feld, Daniel O. Sánchez, et al.. (2002). Hepatitis B virus S gene mutants in a patient with chronic active hepatitis with circulating Anti‐HBs antibodies. Journal of Medical Virology. 69(1). 18–26. 40 indexed citations
17.
Mandό, Oscar G., et al.. (1997). [Liver histology in chronic hemodialysis patients infected with hepatitis C virus].. PubMed. 57(5). 541–5. 4 indexed citations
18.
Elsner, Boris, et al.. (1973). Pathology of 12 fatal cases of Argentine hemorrhagic fever. American Journal of Tropical Medicine and Hygiene. 22(2). 229–236. 46 indexed citations
19.
Elsner, Boris, et al.. (1970). [Pathology of Argentine hemorrhagic fever].. PubMed. 30. 1:85–94. 4 indexed citations
20.
Mandό, Oscar G., et al.. (1970). [Symptoms and early signs of major diagnostic value in Argentine hemorrhage fever].. PubMed. 30. Suppl 1:8–14. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mark S. Sulkowski Breakdown of academic impact, for papers by William N. Katkov Breakdown of academic impact, for papers by Victoria T. Mücke Breakdown of academic impact, for papers by E. K. W. Chiu Breakdown of academic impact, for papers by Faleh Z. Al-Faleh Breakdown of academic impact, for papers by Javier Graus Breakdown of academic impact, for papers by N. Qurishi Breakdown of academic impact, for papers by María Sales Gilabert Breakdown of academic impact, for papers by Jeanne Serpaggi Breakdown of academic impact, for papers by Luis Viola
Rankless by CCL
2026